Article Versions Notes

Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, Stöhr R, Geppert C, Weyerer V, Bertz S, et al. CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage. Cancers. 2020; 12(5):1253. https://doi.org/10.3390/cancers12051253

Eckstein, Markus, Elena Epple, Rudolf Jung, Katrin Weigelt, Verena Lieb, Danijel Sikic, Robert Stöhr, Carol Geppert, Veronika Weyerer, Simone Bertz, and et al. 2020. "CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage" Cancers 12, no. 5: 1253. https://doi.org/10.3390/cancers12051253

Eckstein, M., Epple, E., Jung, R., Weigelt, K., Lieb, V., Sikic, D., Stöhr, R., Geppert, C., Weyerer, V., Bertz, S., Kehlen, A., Hartmann, A., Wullich, B., Taubert, H., & Wach, S. (2020). CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage. Cancers, 12(5), 1253. https://doi.org/10.3390/cancers12051253